循环脂联素:肝细胞癌的一种潜在预后指标OACSTPCD
Circulating adiponectin: a potential prognostic marker for hepatocellular carcinoma
Objective: We planned this study to investigate the relation between serum adiponectin level and hepatocel-lular carcinoma (HCC): risk, features and prognosis. Methods: The study included 100 patients with HCC and 40 healthy control subjects. Adiponectin levels were determined by an enzyme-linked immunosorbent assay kit. Results: In the subset of patients with compensated cirrhosis, the mean serum adiponectin level was significantly lower in HCC cases …查看全部>>
Mohamed E. E. Shams;Mohammed M. H. Al-Gayyar;Enaase A. M. E. Barakat;Mohamed A. Ebrahim;Mamdouh M. El-Shishtawy
Department of Pharmaceutics, Faculty of Pharmacy, University of Mansoura, Mansoura, EgyptDepartment of Biochemistry, Faculty of Pharmacy, University of Mansoura, Mansoura, EgyptDepartment of Internal Medicine, Faculty of Medicine, University of Mansoura, Mansoura, EgyptDepartment of Internal Medicine, Faculty of Medicine, University of Mansoura, Mansoura, EgyptDepartment of Biochemistry, Faculty of Pharmacy, University of Mansoura, Mansoura, Egypt
adiponectin hepatocellular carcinoma (HCC) prognostic marker
adiponectin hepatocellular carcinoma (HCC) prognostic marker
《中德临床肿瘤学杂志（英文版）》 2011 (10)
570-574,5
评论